AR045996A1 - Formulaciones semi-solidas para la administracion oral de taxoides - Google Patents

Formulaciones semi-solidas para la administracion oral de taxoides

Info

Publication number
AR045996A1
AR045996A1 ARP040102493A ARP040102493A AR045996A1 AR 045996 A1 AR045996 A1 AR 045996A1 AR P040102493 A ARP040102493 A AR P040102493A AR P040102493 A ARP040102493 A AR P040102493A AR 045996 A1 AR045996 A1 AR 045996A1
Authority
AR
Argentina
Prior art keywords
semi
taxoids
oral administration
solid formulations
mixture
Prior art date
Application number
ARP040102493A
Other languages
English (en)
Spanish (es)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR045996A1 publication Critical patent/AR045996A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP040102493A 2003-07-18 2004-07-15 Formulaciones semi-solidas para la administracion oral de taxoides AR045996A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291795A EP1498120A1 (en) 2003-07-18 2003-07-18 Semi-solid formulations for the oral administration of taxoids

Publications (1)

Publication Number Publication Date
AR045996A1 true AR045996A1 (es) 2005-11-23

Family

ID=33462258

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102493A AR045996A1 (es) 2003-07-18 2004-07-15 Formulaciones semi-solidas para la administracion oral de taxoides

Country Status (20)

Country Link
US (1) US20050070496A1 (cg-RX-API-DMAC7.html)
EP (2) EP1498120A1 (cg-RX-API-DMAC7.html)
JP (1) JP5116306B2 (cg-RX-API-DMAC7.html)
KR (1) KR101143341B1 (cg-RX-API-DMAC7.html)
CN (1) CN1826110B (cg-RX-API-DMAC7.html)
AR (1) AR045996A1 (cg-RX-API-DMAC7.html)
AT (1) ATE388701T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004262496B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412759A (cg-RX-API-DMAC7.html)
CA (1) CA2532667A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004012413T2 (cg-RX-API-DMAC7.html)
DK (1) DK1648440T3 (cg-RX-API-DMAC7.html)
ES (1) ES2303642T3 (cg-RX-API-DMAC7.html)
IL (1) IL173110A (cg-RX-API-DMAC7.html)
IN (1) IN229997B (cg-RX-API-DMAC7.html)
MX (1) MX260260B (cg-RX-API-DMAC7.html)
MY (1) MY137965A (cg-RX-API-DMAC7.html)
PT (1) PT1648440E (cg-RX-API-DMAC7.html)
TW (1) TWI342774B (cg-RX-API-DMAC7.html)
WO (1) WO2005013968A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
US20080045589A1 (en) * 2006-05-26 2008-02-21 Susan Kelley Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
FR2924024B1 (fr) 2007-11-27 2012-08-17 Centre Nat Rech Scient Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse
FR2931152B1 (fr) * 2008-05-16 2010-07-30 Centre Nat Rech Scient Nouveau systeme de transfert d'acide nucleique
WO2011051894A1 (en) 2009-10-29 2011-05-05 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
AU2011248449B2 (en) 2010-05-03 2016-09-15 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103980232A (zh) * 2014-06-05 2014-08-13 北京诺普德医药科技有限公司 10-乙酰基多西紫杉醇及其用途
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
CN113698369A (zh) * 2021-08-31 2021-11-26 无锡紫杉药业有限公司 一种除去卡巴他赛中特定单杂的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5478854A (en) * 1992-10-01 1995-12-26 Bristol-Myers Squibb Company Deoxy taxols
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
WO1999049848A1 (en) * 1998-04-01 1999-10-07 Rtp Pharma Inc. Anticancer compositions
MXPA01011981A (es) * 1999-05-24 2003-09-04 Sonus Pharma Inc Vehiculo de emulsion para farmacos poco solubles.
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
JP2004520398A (ja) * 2001-01-18 2004-07-08 ファルマシア・アンド・アップジョン・カンパニー 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物
WO2003045357A1 (en) * 2001-11-27 2003-06-05 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
RS52904A (sr) * 2001-12-20 2006-12-15 Bristol-Myers Squib Company Farmaceutske smeše oralno aktivnih derivata taksana koje imaju povećanu bioraspoloživost
WO2003074027A2 (en) * 2002-03-01 2003-09-12 Novagali Pharma Sa Self emulsifying drug delivery systems for poorly soluble drugs
KR20090072980A (ko) * 2007-12-28 2009-07-02 서울옵토디바이스주식회사 발광 다이오드 및 그 제조방법

Also Published As

Publication number Publication date
AU2004262496B2 (en) 2009-02-05
MY137965A (en) 2009-04-30
MX260260B (es) 2008-09-04
CN1826110A (zh) 2006-08-30
HK1091743A1 (zh) 2007-01-26
AU2004262496A1 (en) 2005-02-17
BRPI0412759A (pt) 2006-09-26
IN2006CH00198A (cg-RX-API-DMAC7.html) 2007-06-08
DK1648440T3 (da) 2008-07-14
EP1648440A1 (en) 2006-04-26
ES2303642T3 (es) 2008-08-16
DE602004012413D1 (de) 2008-04-24
CA2532667A1 (en) 2005-02-17
WO2005013968A1 (en) 2005-02-17
CN1826110B (zh) 2010-05-12
KR101143341B1 (ko) 2012-05-24
JP2009513558A (ja) 2009-04-02
MXPA06000636A (es) 2006-04-19
JP5116306B2 (ja) 2013-01-09
ATE388701T1 (de) 2008-03-15
EP1648440B1 (en) 2008-03-12
IL173110A (en) 2011-04-28
EP1498120A1 (en) 2005-01-19
IN229997B (cg-RX-API-DMAC7.html) 2009-03-27
PT1648440E (pt) 2008-06-24
TW200517104A (en) 2005-06-01
US20050070496A1 (en) 2005-03-31
TWI342774B (en) 2011-06-01
IL173110A0 (en) 2006-06-11
DE602004012413T2 (de) 2009-03-12
KR20060037370A (ko) 2006-05-03

Similar Documents

Publication Publication Date Title
AR045996A1 (es) Formulaciones semi-solidas para la administracion oral de taxoides
HN2010002735A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidrobenzo(1,4)dioxin-2-ilmetil)-sulfamida
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
MX2008009358A (es) Una formulacion farmaceutica de taxano, una composicion solida de taxano, un procedimiento para la preparacion de dicha composicion solida de taxano, una composicion solubllizante de dicha composicion solida de taxano, y un conjunto de elementos (kit
MXPA03000065A (es) Composiciones de micelas polimericas.
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
UY28862A1 (es) Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
CR7716A (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
UY28231A1 (es) Metodos y composiciones farmacéuticas para la obtención confiable de niveles aceptables de testosterona en suero.
AR109263A2 (es) Composición que comprende moxidectina
PA8581801A1 (es) Formulaciones que contienen un compuesto de indolinona
NO20060977L (no) Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter
AR024998A1 (es) Nuevos retinoides para el tratamiento del enfisema
AR122059A1 (es) Usos y formulaciones de cannabinoides
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
AR032138A1 (es) Derivados de 6-hidroxi-indazol, una composicion oftalmica, y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de glaucoma
AR118823A1 (es) Uso de cannabidiol en el tratamiento del complejo de esclerosis tuberosa
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
PE20211198A1 (es) Metodos y formulaciones para tratar nauseas y vomitos inducidos por quimioterapia

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure